Dr. Michelle L. McKeague (née Miller) is the Assistant Director of Platforms at the Institute for Immunology and Immune Health at the University of Pennsylvania. After obtaining an A.B. in Biology from Washington University in St. Louis, she completed her Master's in Translational Research through the HHMI Med-Into-Grad program and her PhD studies in Pathology at the University of Chicago. Under the mentorship of Dr. Maria-Luisa Alegre, her dissertation research investigated mechanisms underlying organ transplantation tolerance and was funded by a T32 award from the NIH and two fellowships from the American Heart Association. She completed her postdoctoral training in tumor immunology in Dr. Olivera Finn's laboratory at the University of Pittsburgh with support from NCI T32 and F32 awards. Her current work focuses on scaling human immune system profiling across health and disease.
Dr. Michelle L. McKeague (née Miller) is the Assistant Director of Platforms at the Institute for Immunology and Immune Health at the University of Pennsylvania. After obtaining an A.B. in Biology from Washington University in St. Louis, she completed her Master's in Translational Research through the HHMI Med-Into-Grad program and her PhD studies in Pathology at the University of Chicago. Under the mentorship of Dr. Maria-Luisa Alegre, her dissertation research investigated mechanisms underlying organ transplantation tolerance and was funded by a T32 award from the NIH and two fellowships from the American Heart Association. She completed her postdoctoral training in tumor immunology in Dr. Olivera Finn's laboratory at the University of Pittsburgh with support from NCI T32 and F32 awards. Her current work focuses on scaling human immune system profiling across health and disease.